Vivos Therapeutics, Inc. - Common Stock (VVOS)

Competitors to Vivos Therapeutics, Inc. - Common Stock (VVOS)

ApniCure

ApniCure specializes in non-invasive devices for the treatment of OSA, posing direct competition to Vivos Therapeutics. Both companies aim to provide alternatives to traditional CPAP therapy, focusing on improving patient comfort and compliance. While Vivos emphasizes its therapeutic approach incorporating orthodontic principles, ApniCure leverages technology for ease of use and effectiveness, presenting a balanced competition with each offering unique advantages to patient segments.

Innovative Health Solutions, Inc.

Innovative Health Solutions, Inc. develops non-invasive therapies for sleep apnea that synergize with Vivos' offerings. The company employs a range of therapeutic methods, including lifestyle modification and guidance programs, to address OSA. Although Innovative Health Solutions has innovative treatment options, Vivos holds a unique position by focusing on dental implications and long-term orthopedic adjustments, suggesting a differentiation in offering even if they target the same patient demographic.

ResMed Inc. 

ResMed Inc. is a global leader in digital health and cloud-connected devices, specializing in sleep apnea devices and solutions. ResMed competes with Vivos Therapeutics by offering advanced CPAP solutions and a digital ecosystem that enhances patient monitoring and compliance. ResMed's established market presence, significant R&D investment, and strong partnership ecosystem give it a competitive advantage over new entrants like Vivos, which relies on a less conventional treatment approach.

Sleep apnea treatment devices

Various companies produce CPAP machines and other individually tailored sleep therapy solutions that compete with Vivos' oral appliance therapy. These devices are often seen as the standard treatment for sleep apnea, providing an established alternative for consumers. Companies leading in the CPAP space benefit from strong brand loyalty and extensive clinical backing, which present significant challenges for Vivos' entry into traditional sleep disorder treatment markets.

SomnoMed Limited

SomnoMed Limited specializes in the development and manufacturing of oral appliances for the treatment of obstructive sleep apnea (OSA), which directly competes with Vivos Therapeutics' innovative approach to treating sleep apnea through its proprietary therapy. While Vivos focuses on a combination of oral devices and treatment protocols often supported by orthodontic principles, SomnoMed has a well-established product line and a strong distribution network, providing it with a significant competitive edge in market penetration and brand recognition.